The pregnant women living with hiv antiretroviral therapy coverage for pmtct in the Philippines has dropped to 6%, which is a decrease of 7% (-53.8%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in the Philippines
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to the Philippines
PMTCT antiretroviral therapy coverage
More indicators for the Philippines
Male unintentional poisoning
0.3
0.0
(2019)
Female wasting in children
5.5%
+0.4%
(2021)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar231
+intl dollar12
(2022)
Birth registration
91.8%
+1.6%
(2017)
Contraceptive modern method prevalence
40.4%
+2.8%
(2017)
Philippines PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 6% | -7% |
| 2021 | 13% | -8% |
| 2020 | 21% | -1% |
| 2019 | 22% | +4% |
| 2018 | 18% | +2% |
| 2017 | 16% | 0% |
| 2016 | 16% | +2% |
| 2015 | 14% | +2% |
| 2014 | 12% | +3% |
| 2013 | 9% | -5% |
| 2012 | 14% | -2% |
| 2011 | 16% | +2% |
| 2010 | 14% | +14% |
| 2009 | 0% | 0% |
| 2008 | 0% | 0% |
| 2007 | 0% | 0% |
| 2006 | 0% | 0% |
| 2005 | 0% | 0% |
| 2004 | 0% | 0% |
| 2003 | 0% | 0% |
| 2002 | 0% | 0% |
| 2001 | 0% | 0% |
| 2000 | 0% |